Imperial Oil 2Q Profit Rises on Crude Price, Supply Volatility
Dow Jones2026/07/31 12:20By Adriano Marchese
Imperial Oil's second-quarter profit surged thanks to crude oil supply volatility and higher prices caused by the conflict in the Middle East, offsetting decreased production.
The Canadian energy company posted a jump in net income to 2.19 billion Canadian dollars ($1.56 billion), or C$4.52 a share, up from C$949 million, or C$1.86 a share, in the comparable quarter a year ago.
Imperial Oil benefited from higher prices and volatility of crude oil caused by the war and subsequent tensions in the Middle East, where the U.S. and Israel came into conflict with Iran.
Cash flows from operating activities came to C$2.7 billion, up from C$1.47 billion a year earlier.
Total revenues rose to C$16.06 billion from C$11.23 billion the prior year, topping expectations of C$15.51 billion.
Upstream production fell to 414,000 barrels of oil equivalent a day, down from 427,000 barrels a day, due to lower volumes.
The company refined 331,000 barrels a day, down from 376,000 barrels a day a year earlier due to lower capacity utilization.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
July 31, 2026 08:20 ET (12:20 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Uniswap.com Domain Story Resurfaces After SBF Purchase Claim
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).